-
NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Rating of "Buy" by Analysts
来源: Buzz FX / 26 12月 2024 04:26:13 America/Chicago
NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Rating of "Buy" by Analysts Written by MarketBeat December 26, 2024 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) has received a consensus recommendatio
Read more...